Search results
Pancreatic cancer: Some signs that cancer has spread
Medical News Today· 5 days agoWhen pancreatic cancer spreads to other areas of the body, a person may experience new symptoms that are not directly linked to the tumors in the...
The growing promise of cancer vaccines
Cosmos· 11 hours agoA cure for cancer — which is second only to cardiovascular diseases in its contribution to the global burden of disease — has long been a dream. While no magic bullet is yet ...
ASCO 2024: Verastem’s combo therapy for pancreatic cancer hits early trial success
Clinical Trials Arena via Yahoo Finance· 2 days agoVerastem Oncology reported positive initial results from an ongoing Phase I/II trial investigating...
Biotechs Zero in on New Pancreatic Therapies as Global Pancreatic Cancer Market Expected Reach to...
Morningstar· 2 days agoFN Media Group News Commentary - The pancreatic cancer market encompasses the pharmaceutical and healthcare sectors dedicated to addressing the prevention ...
For most, pancreatic cancer is a deadly diagnosis. How one Fort Worth man beat the odds
Fort Worth Star-Telegram McClatchy via AOL· 6 days ago“Where we are now for pancreatic cancer is where we were for colon cancer maybe 40 years ago,”...
Verastem (VSTM) Up on Upbeat Early Pancreatic Cancer Study Data
Zacks via Yahoo Finance· 2 days agoVerastem (VSTM) gains 57% post-market on achieving a confirmed partial response in 83% of first-line...
BioLineRx reports positive pancreatic cancer trial results By Investing.com
Investing.com· 2 days agoBioLineRx Ltd. (NASDAQ: BLRX), a biopharmaceutical company, announced encouraging results from the...
Liposomal Irinotecan for Pancreatic Cancer: Is It Worth It?
Medscape· 5 days agoIn February, the US Food and Drug Administration approved irinotecan liposome (Onivyde) as part of a...
What's Going On With Mid-Cap Cancer-Focused Verastem Oncology Stock On Friday?
Benzinga via AOL· 2 days agoThe initial interim results will be presented at the upcoming American Society of Clinical Oncology...
CANTEX PHARMACEUTICALS RECEIVES FDA ORPHAN DRUG DESIGNATION FOR AZELIRAGON FOR THE TREATMENT OF ...
WKRN Nashville· 6 days agoFood and Drug Administration (FDA) has granted Orphan Drug Designation to Cantex' azeliragon, a well-tolerated once-a-day pill, for the treatment of pancreatic< ...
